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Background: The capacity of muscle to grow or to regenerate after damage is provided by adult stem cells, so
called satellite cells, which are located under the basement lamina of each myofiber. Upon activation satellite cells
enter the cell cycle, proliferate and differentiate into myoblasts, which fuse to injured myofibers or form new fibers.
These processes are tightly controlled by many growth factors.
Results: Here we investigate the role of bone morphogenetic proteins (BMPs) during satellite cell differentiation.
Unlike the myogenic C2C12 cell line, primary satellite cells do not differentiate into osteoblasts upon BMP
signaling. Instead BMP signaling inhibits myogenic differentiation of primary satellite cells ex vivo. In contrast,
inhibition of BMP signaling results in cell cycle exit, followed by enhanced myoblast differentiation and myotube
formation. Using an in vivo trauma model we demonstrate that satellite cells respond to BMP signals during the
regeneration process. Interestingly, we found the BMP inhibitor Chordin upregulated in primary satellite cell
cultures and in regenerating muscles. In both systems Chordin expression follows that of Myogenin, a marker for
cells committed to differentiation.
Conclusion: Our data indicate that BMP signaling plays a critical role in balancing proliferation and differentiation
of activated satellite cells and their descendants. Initially, BMP signals maintain satellite cells descendants in a
proliferating state thereby expanding cell numbers. After cells are committed to differentiate they upregulate the
expression of the BMP inhibitor Chordin thereby supporting terminal differentiation and myotube formation in a
negative feedback mechanism.
Background
Adult muscle tissue is characterized by its capacity to
grow after exercise and to regenerate after injury. Both
processes require stem cells - so called satellite cells,
which are located between the myofiber membrane and
the surrounding basement lamina [1]. Activation of
quiescent satellite cells by external stimuli, like exercise
or injury, leads to their re-entry into the cell cycle to
provide myoblasts to the regenerating muscle. While
most of the satellite cell descendants are committed to
differentiate, either by fusing to existing fibers or by
forming new myofibers, some of these cells do not enter
the differentiation program, but exit the cell cycle and
return to a quiescent state [2]. The activated satellite
cells will thus not only provide myonuclei to the regen-
erating muscle but will also replenish the stem cell
reservoir [3-5].
During satellite cell differentiation distinct phases can
be distinguished, which are characterized by the expres-
sion of different transcription factors. The paired-box
transcription factor Pax7, a marker widely used to iden-
tify satellite cells, is expressed in quiescent satellite cells
[6]. Activated satellite cells maintain Pax7 expression
and, in parallel, upregulate MyoD, a member of the
family of myogenic regulatory factors (MRFs). MyoD
expression is maintained during proliferation and early
differentiation [5,7-10]. Commitment to differentiation
is characterized by the onset of Myogenin expression,
another member of the group of MRFs [5,7-10]. Upon
terminal differentiation postmitotic satellite cell descen-
dants fuse into myotubes and start to express muscle
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of these transcription factors adult regenerative myogen-
esis largely recapitulates the embryonic and fetal pro-
gram of muscle differentiation.
During the last years various growth factors and sig-
naling pathways have been identified that control myo-
blast differentiation during embryogenesis. The process
of self-renewal, for example, has been linked to canoni-
cal Wnt signaling as well as to the non-canonical planar
cell polarity pathway [11,12].
Hepatocyte growth factor (Hgf) is one of the key regu-
lators during activation of quiescent satellite cells. Dif-
ferent studies demonstrate that Hgf, released from the
muscle extracellular matrix immediately after injury, sig-
nals to the Hgf receptor c-met, which is expressed in
quiescent satellite cells [13-15]. The expansion of the
satellite cell pool is positively regulated by Fibroblast
growth factors (FGFs), which activate proliferation
synergistically to Hgf [16]. Furthermore, the expression
of Fgf receptor 4 (Fgfr4) has been reported to be upre-
gulated during satellite cell activation [17]. Besides a
potential role during satellite cell activation, FGFs con-
trol proliferation of satellite cells in vitro and in vivo
[10,18].
Another important group of signaling factors regulat-
ing satellite cell differentiation are members of the
Transforming growth factor b (TGFb) family. Tgfb1, the
best-characterized family member during adult myogen-
esis, has been shown to inhibit satellite cell proliferation
and differentiation in vitro and to negatively regulate
muscle growth and regeneration in vivo[19]. TGFb sig-
naling requires binding of the ligand to type I and type
II receptors, leading to the formation of a hetero-tetra-
meric receptor complex. Phosphorylation of type I by
type II receptors leads to the subsequent phosphoryla-
tion of receptor regulated SMAD proteins, which form
heterodimers with the common coactivator Smad 4.
These complexes translocate to the nucleus, where they
function as transcription factors to regulate TGFb target
gene expression [20].
Bone morphogenetic proteins (BMPs) form a sub-
group of the TGFb family of growth factors. BMPs regu-
late target gene expression via phosphorylation of Smad
1, 5 and 8. The activity of BMPs is negatively regulated
by secreted BMP inhibitors, like Noggin and Chordin,
which inhibit binding of the growth factors to their
receptors [21]. BMPs have originally been identified by
their capacity to induce bone formation when injected
into adult rat muscles [22]. The osteogenic effect of
BMPs was intensively studied in C2C12 cells, a cell line
derived from regenerating muscle. C2C12 cells will form
multinucleated myotubes upon serum starvation, but
will differentiate into osteoblasts upon stimulation with
BMPs [23-25]. Due to this observation BMP signaling
has not been intensively studied in the context of adult
myogenesis. In contrast to these cell culture experiments
several studies have identified BMPs as regulators of
chick embryonic myogenesis in somites and limbs
[26-28]. Based on these findings we have re-analyzed the
role of BMP signals during satellite cell differentiation
using C2C12 cells and primary adult mouse satellite
cells. We found that BMPs keep satellite cell descen-
dants in a proliferating state, while cell cycle exit and
myotube formation is induced by inhibition of BMP sig-
naling. We also demonstrated that the BMP pathway is
activated during in vivo muscle regeneration.
Results
Inhibition of BMP signaling triggers myogenic
differentiation in C2C12 cells
To gain first insight into a potential role of BMP signal-
ing during satellite cell differentiation we examined
myogenic differentiation of C2C12 cells after treatment
with Bmp7 and Noggin (Figure 1; n = 6). As C2C12
cells have been described to transdifferentiate into
osteoblasts if treated with BMPs we first monitored the
expression of alkaline phosphatase, which is expressed
in osteoblasts but not in cells of the myogenic lineage
(Figure 1D-F). As expected, a subset of cells treated
with Bmp7 for 3 days showed enzymatic activity of alka-
line phosphatase (Figure 1E) [25]. In contrast, in
untreated or Noggin-treated cultures no differentiation
of alkaline phosphatase expressing osteoblasts could be
detected (Figure 1D, F). We next analyzed the extent of
myogenic differentiation by immunostaining with the
muscle myosin heavy chain (MHC) antibody A4.1025,
which recognizes all isoforms of skeletal muscle MHCs
in terminally differentiated myoblasts (Figure 1A-C,G).
In Bmp7-treated cultures only single myoblasts
expressed MHC and myogenic differentiation was signif-
icantly decreased (0.5%) compared to untreated cultures
(5%; p < 0.005). Interestingly, in comparison to control
cultures, Noggin-treated cultures showed significantly
increased numbers of MHC expressing cells and
enhanced myotube formation (8%; p < 0.005).
Besides the inhibitory effect on myogenic differentia-
tion, Bmp7 treatment led to a significantly increased cell
number in C2C12 cultures compared to non-treated
and Noggin-treated cultures (130%; p < 0.005; Figure
1H). To test if Bmp7 regulates proliferation of C2C12
cells, thereby preventing cell cycle exit and myogenic
differentiation, we measured 5-bromo-2’-deoxyuridine
(BrdU) incorporation during S-phase after 3 days in cul-
ture. (Figure 1I). After treatment with Bmp7, the pro-
portion of cells in S-phase was increased to 15%
compared to 11% in untreated and 9.5% in Noggin-trea-
ted cultures (Figure 1I) (p < 0.05) [29]. In addition to
the reduced number of cells in S-phase, numerous cells
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Page 2 of 17Figure 1 Bmp7 and Noggin regulate terminal differentiation of C2C12 cells in opposite ways. C2C12 cells were treated in control
medium (A,D,J) or supplemented with Bmp7 (B,E,K) or Noggin (C,F,L) and analyzed for terminal myogenic differentiation (MHC expression) (A-C),
osteoblast differentiation (alkaline phosphatase activity) (D-F), BrdU incorporation (I) and apoptosis (J-L). (A-C) terminally differentiated, MHC
expressing myoblasts/myotubes can be detected in control cultures (A). Bmp7 treatment inhibits myogenic differentiation (B), whereas Noggin
treatment leads to enhanced myotube formation (C). DAPI was used to counterstain nuclei (100× magnification). (D-F) C2C12 cells express
alkaline phosphatase upon Bmp7 treatment (E) but not in untreated (D) or Noggin-treated cultures (F) (50× magnification). (G) Statistical analysis
using the generalized Wilcoxon test demonstrates significantly reduced numbers of MHC-positive cells after Bmp7 treatment and increased
numbers after Noggin treatment (n = 6, 2 individual experiments in triplicates; *p < 0.005). Cell number (H) and BrdU incorporation (I) are
upregulated after Bmp7 treatment (n = 6, 2 individual experiments in triplicates *p < 0.005; Wilcoxon test). (J-L) the apoptotic marker cleaved
Caspase3 is absent after Bmp7 treatment (K) while apoptosis can be detected in control (J) and Noggin-treated cultures (L) (200× magnification).
Friedrichs et al. BMC Cell Biology 2011, 12:26
http://www.biomedcentral.com/1471-2121/12/26
Page 3 of 17detached from the culture well within control and Nog-
gin-treated cultures. To investigate if apoptosis is
induced during differentiation of C2C12 cells due to
growth factor starvation, we analyzed the presence of
cleaved Caspase-3, which triggers the apoptotic process
[30,31]. While cleaved Caspase-3-positive, apoptotic
cells were detected within the non-treated and Noggin-
treated cultures, hardly any apoptotic cells could be
detected after Bmp7 treatment (Figure 1J-L) [32]. In
summary, the increased cell density in combination with
the increased number of cells in S-phase and the
reduced number of MHC- and caspase-3-positive cells
indicate that Bmp7 signaling protects C2C12 cells from
differentiation and apoptosis keeping them in a prolifer-
ating state. In contrast inhibition of BMP signaling trig-
gers myogenic differentiation, thereby reducing the
number of cells in S-phase.
Activated satellite cells respond to BMP signals
As myogenic differentiation is regulated by BMP signal-
ing in C2C12 cells we next asked if satellite cells react
to BMP signals ex vivo in a similar way. To address this
question, we cultured primary satellite cells for 0, 24, 48
and 72 hours on floating myofibers and analyzed the
expression of the well-characterized, stage specific tran-
scription factors Pax7, MyoD and Myogenin in relation
to BMP induced phosphorylation of Smad 1/5/8 (p-
Smad) by double immunolabeling (Figure 2) [5,33,34].
As previously described, quiescent satellite cells on
freshly isolated myofibers express Pax7 only (Figure 2A-
D). After 24 hours in culture, a time point at which
most satellite cells have not yet divided, Pax7 co-loca-
lized with MyoD, which marks activated, proliferating
and early differentiating satellite cells [34] (Figure 2I-L).
At 48 hours, many satellite cells had completed their
first cell divisions and expressed Pax7 and MyoD, but
not the differentiation marker Myogenin, which marks
myoblasts commited to differentiate (Figure 2M-P, Q-
T). First nuclear Myogenin could be detected after 72
hours (Figure 2U-X) [5]. We did not detect any p-
Smad-positive satellite cells on freshly isolated myofibers
(n > 50; Figure 2A-D). Furthermore, no p-Smad staining
could be detected in the myonuclei of the fiber (Figure
2A-H, M-P, U-X). At 24 and 48 hours, when satellite
cell descendants were still proliferating and had not yet
started to differentiate (Myogenin-negative; Figure 2Q-
T), all Pax7-positive, MyoD-positive satellite cells were
positive for p-Smad (n > 50; Figure 2E-H, M-P). At 72
hours when cells became committed to differentiate, p-
Smad and Myogenin colocalize in a subset of cells (Fig-
ure 2U-X). Together these data indicate that quiescent
satellite cells do not react to BMP signals, but respond
to BMP signals upon activation. Furthermore, BMP
responsiveness is maintained during early differentiation
stages, but is absent in terminally differentiated myonu-
clei of the fiber.
BMP signals maintain expression of Pax7 in satellite cells
Satellite cells grown in vitro are exposed to many
growth factors present in the culture medium. To test if
freshly isolated satellite cells respond to BMP signals
directly or if the competence to respond requires other
growth factors, we cultivated satellite cells on myofibers
under serum-free conditions and treated with Bmp7
(Figure 3; n = 3). After 18 hours in culture p-Smad-
positive cells were present on each myofiber treated
with Bmp7 (Figure 3I-L). Similar to satellite cells cul-
tured in growth factor rich medium, p-Smad colocalized
with Pax7 upon Bmp7 treatment under serum-free con-
ditions (Figure 3A-D, I-L). In contrast, on fibers, which
did not receive Bmp7 under serum free conditions, we
could hardly detect nuclear p-Smad in satellite cells
(Figure 3E-H). Surprisingly, in these untreated cells the
expression of Pax7, the marker for quiescent satellite
cells, was strongly reduced, (Figure 3E-H). Quantifica-
tion of the fluorescence intensity of the Pax7 signal per
nucleus, which reflects the expression level of Pax7,
revealed a significant decrease to 50% within 24 hours
in the absence of Bmp7 (p = 0.005; n = 30; Figure 3M).
We therefore conclude that satellite cells are competent
to directly react to BMP signals by phosphorylation of
Smad 1/5/8 under serum-free cultures. Furthermore,
strong activation of BMP signaling seems to be sufficient
to maintain Pax7 expression under these conditions.
BMP signals inhibit differentiation of primary satellite
cells
T of u r t h e ra n a l y z et h er o l eo fB M Ps i g n a l i n gd u r i n g
satellite cell differentiation, we treated primary satellite
cells cultured on matrigel under mitogen-restricted con-
ditions with Bmp7 and Noggin. As Bmp7 treatment
induced osteoblast differentiation in C2C12 cells we first
analyzed the expression of the osteoblast marker alka-
line phosphatase in parallel to Desmin, an intermediate
filament protein specifically expressed in cells of the
myogenic lineage (Figure 4; n ≥ 6). No expression of
alkaline phosphatase could be detected (Figure 4M-P),
demonstrating that, in contrasts to C2C12 cells, Bmp7
treatment does not induce osteoblast differentiation in
primary satellite cells. Instead, all differentiating myo-
blasts from untreated (Figure 4A-C), Bmp7 (Figure 4D-
F) and Noggin-treated cultures (Figure 4G-I) expressed
the myoblast lineage marker Desmin (n ≥ 13). Further-
more, formation of MHC-positive myotubes could be
detected under each culture condition (Additional file 1,
Figure S1; n = 6).
To characterize the role of BMP signaling during the
differentiation of primary satellite cells, we first counted
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tures. As expected, the total number of myonuclei in
Noggin-treated cultures was significantly reduced (64%;
p < 0.005) compared to untreated cultures, whereas it
was increased after Bmp7 treatment (121%; p = 0.05;
Figure 4J, n ≥ 13). Nevertheless, the relative number of
fused myonuclei in Desmin-positive myotubes was
decreased upon Bmp7 treatment (20%; p = 0.002),
whereas Noggin treatment led to significantly enhanced
myotube formation (47%) compared to untreated con-
trols (Figure 4K; 28%; p < 0.005; n ≥ 13). Consequently,
the fraction of mononucleated cells was significantly
reduced upon Noggin treatment (data not shown).
As BMPs seem to keep C2C12 cells in a proliferating
state we next investigated their effect on satellite cell pro-
liferation by labeling S-phase nuclei at the end of a 3 day
differentiation period for 2 hours with BrdU. MHC immu-
nostaining was used to identify terminally differentiated
Figure 2 Activated satellite cells respond to BMP signals. Satellite cells attached to myofibers were analyzed after 0 (A-D), 24 (E-L), 48 (M-T)
and 72 hours (U-X) in culture by co-immunostaining for Pax7 (A,E,I,M), myogenin (Q,U), MyoD (J,R) sein and p-Smad 1/5/8 (B,F,N,V) as indicated.
(A-D) p-Smads are absent in quiescent satellite cells. (E-L) Satellite cells co-express Pax7, MyoD and p-Smads after 24 hours. (M-T) after 48 hours
Pax7 and MyoD are co-expressed with p-Smad, while Myogenin is absent. (U-X) Myogenin colocalizes with p-Smad after 72 hours. Nuclei were
counterstained with DAPI. Magnification is 200×.
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undifferentiated, mononucleated cells, only. No statistically
significant differences could be detected between the
Bmp7-treated (15.1%, p = 0.11), the Noggin-treated
(17.02%; p ≥ 0.1) and the control cultures (18.18%). It
seems thus not likely that Bmp7 or Noggin treatment has
major effects on cell cycle kinetics.
To estimate if treatment with Bmp7 or Noggin alters
the number of cells committed to differentiate we next
counted Desmin and Myogenin doublestained, mononu-
cleated cells within the cultures. In Bmp7-treated cul-
tures the relative number of Myogenin-positive,
mononucleated cells was significantly reduced, strongly
supporting the assumption that BMP signals inhibit the
commitment to differentiation. Interestingly, after 3 days
of Noggin treatment the relative number of Desmin-
and Myogenin-positive, mononucleated cells was
decreased as well (Figure 4L; n = 6). These data are in
agreement with our hypothesis that BMP signaling
keeps myoblasts proliferating and prevents the commit-
ment to differentiation, whereas inhibition of BMP sig-
naling supports commitment to terminal myoblast
differentiation, leading to a rapid fusion of the myo-
genin-positive cells into myotubes.
Figure 3 Bmp7 maintains Pax7 expression in satellite cells. Satellite cells were cultured on myofibers for 18 hours under standard (A-D) or
serum free (SR) (E-L) conditions. (A-D) p-Smad colocalize with Pax7 in standard medium. (I-L) In serum free cultures Bmp7 treatment induces p-
Smad phosphorylation in Pax7-positive cells. In untreated cultures p-Smad cannot be detected (E-H). Absence of p-Smad causes a severe
downregulation of Pax7. Nuclei were counterstained with DAPI. Magnification is 400×. (M) Analysis of the mean fluorescent intensity of the Pax7
signal in satellite cells revealed a downregulation to 50% in the absence of Bmp7 treatment (n = 30 satellite cells per treatment from 3
individual experiments, * p = 0.005, Wilcoxon test). Magnification is 400×. SR = serum replacement.
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Page 6 of 17Figure 4 BMPs regulate differentiation of primary myoblasts. Myoblasts were treated with Bmp7 (D-F,N) or Noggin (G-I,O) for 3 days under
differentiating conditions and double immunolabeled for Desmin (A,D,G) and Myogenin (B,E,H). Nuclei were counterstained with DAPI (C,F,I).
Boxed areas in the overlay images (C,F,I) are enlarged in (C’,F’,I’). Myoblasts of different cell fates are present within cultures: fused (white arrow in
C’,F ’ and I’), mononucleated/Myogenin-negative (blue arrow in C’,F’,I’) and mononucleated/Myogenin-positive (yellow arrow in C’,F’,I’) cells.
Myotube formation is reduced after Bmp7 stimulation (D-F) compared to control cells (A-C). Enhanced myotube formation was evident after
Noggin treatment (G-I). Magnification is 100×. (J) Statistical analysis revealed a significant decrease in the total number of myonuclei upon
Noggin treatment (n ≥ 13 individual cultures per treatment from 4 independent experiments). (K) Statistical analysis of the relative number of
fused myonuclei (n > 13 individual cultures per treatment from 4 independent experiments) revealed a significant increase in Noggin-treated
cultures compared to untreated controls (*p < 0.005; Wilcoxon test), while Bmp7 treatment lead to a significant decrease in the relative number
of fused myonuclei (*p = 0.002; Wilcoxon test). (L) Analysis of the relative number of Myogenin-positive myonuclei within the population of
mononucleated cells (n > 6 individual cultures per treatment from 2 independent experiments). (M-P) Primary satellite cell descendants do not
express alkaline phosphatase in control (M), Bmp7 (N) and Noggin-treated cultures (O). Staining of a positive control is shown in (P).
Magnification is 50×.
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cell cycle exit we performed a BrdU pulse chase experi-
ment in adherent satellite cell cultures (Figure 5). Directly
before switching to differentiation medium, cultures of
proliferating satellite cells were supplemented with BrdU
for 2 hours. After removal of the BrdU-containing med-
ium cells were differentiated for 3 days in control and
Noggin containing medium (Figure 5A) and analyzed for
BrdU labeling in fused, MHC-positive myotubes. As the
BrdU pulse was received prior to the induction of differen-
tiation, BrdU-positive myonuclei were found within the
MHC-positive myofibers. Based on the idea that nuclei,
which leave the cell cycle directly after the BrdU pulse,
would retain a higher level of the BrdU signal than cells
that keep proliferating and start to differentiate at later
time points, we analyzed the intensity of the BrdU signal
per nucleus (mean fluorescence/per nuclear area) within
MHC-positive myotubes (Figure 5B-E). We then com-
pared the number of highly and less intensively stained
nuclei between the untreated and Noggin-treated cultures.
In untreated cultures most myonuclei in MHC-positive
myotubes exhibited a weak fluorescence signal indicating
that myoblasts had undergone several cell divisions before
fusing into myotubes (Figure 5B-C). In contrast, the pro-
portion of nuclei displaying a more intense BrdU signal
was significantly increased in Noggin-treated cultures (Fig-
ure 5D-F; p < 0.005; n ≥ 92). As BrdU labeling did not
reveal any evidence that Bmp7 or Noggin treatment
altered cell cycle kinetics in mononucleated cells (Addi-
tional file 1, Figure S1), these data further support our
hypothesis that inhibition of BMP signaling stimulates cell
cycle exit and differentiation of proliferating myoblasts.
The p-Smad phoshorylation is lost in terminally
differentiated myotubes
Our initial experiments indicated that nuclei in myofi-
bers do not express p-Smad upon Bmp7 treatment. We
thus asked if the BMP response is already turned off
during the differentiation process. As the floating fiber
culture model is not suitable to analyze later steps of
the differentiation process we analyzed p-Smad in
adherent satellite cell cultures during myotube forma-
tion and maturation (Figure 6). After culturing satellite
cell descendants for 9 days under differentiating condi-
tions most mononucleated and fusing myoblasts were
present in the peripheral regions of clones (Figure 6A-
D), whereas a high proportion of myoblasts had under-
gone fusion into MHC-positive myotubes within the
center of the clones (Figure 6E-H). Whereas mononu-
cleated and fusing cells were mostly p-Smad-positive
most myonuclei within the myotubes were negative for
p-Smad indicating that these ceased to respond to BMP
signals or that BMP inhibitors were expressed during
the differentiation process.
Expression of a BMP inhibitor in primary satellite cell
cultures in vitro
As our data indicate a role for BMP signaling in fine-
tuning proliferation and differentiation in satellite cells
we compared the expression of BMP pathway compo-
nents and BMP inhibitors to that of stage-specific myo-
blast markers in cultured satellite cells attached to
myofibers for 0, 48 and 72 hours (Figure 7). On mRNA
Figure 5 Inhibition of BMP signaling triggers immediate cell
cycle exit of satellite cells. (A) Prior to the induction of
differentiation, cultures of proliferating satellite cells were
supplemented for 2 hours with BrdU and cultured for 3 days in
differentiation medium. Myonuclei within MHC-positive myotubes
from control cultures (B-C) show weak BrdU signals, while Noggin-
treated myonuclei (D-E) show BrdU signals of stronger intensity in
MHC-positive myotubes. (F) Analysis of the mean fluorescence
intensity of the BrdU signal of Noggin-treated cultures (red columns;
n = 92 myonuclei) compared to control cultures (black columns; n
= 117 myonuclei). Histogram showing a shift in the frequency of
Noggin-treated cells to higher levels of BrdU (p < 0,005; Wilcoxon
test).
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myofibers, although protein expression is not detectable
at this stage [9,33]. MyoD expression increased with
time reflecting the elevated number of satellite cells.
Myogenin transcripts were first detected after 48 hours
in culture and its expression was increased after 72
hours, a time point, at which the Myogenin protein
could also be detected (Figure 2U). We next analyzed
the expression of the most abundant BMP pathway
components. We did not find expression of Bmp2,
Bmp4 or Bmp7 under these conditions. Interestingly,
while Noggin expression was below the detection limit,
we found the BMP inhibitor Chordin weakly expressed
at 48 hours and an increased expression at 72 hours
(Figure 7 and data not shown). These data are consis-
tent with the idea that Chordin, as an intrinsic inhibitor
of BMP signaling, supports myoblast differentiation.
Furthermore, increased Chordin expression might also
contribute to the inhibition of BMP signaling and p-
Smad phosphorylation observed in nuclei of fused myo-
fibers (Figure 6).
In vivo function of BMP signaling during muscle
regeneration
In order to link our ex vivo observations to an in vivo
function of BMP signals during muscle regeneration we
analyzed regenerating gastrocnemius muscles of mice
after induction of a blunt closed minor soft tissue
trauma (Figure 8) [35]. Histological analysis of trauma
tissue revealed the invasion of leukocytes into the
injured region 24 hours after trauma induction (Figure
Figure 6 The response to BMP signals decreases during late differentiation stages.( A - H )M y o b l a s t sw e r ec u l t u r e df o r9d a y su n d e r
differentiation conditions and double immunolabeled for p-Smad (B,F) and MHC (C,G). Nuclei were counterstained with DAPI (A,E). Boxed areas
in the overlay images (D,H) are enlarged in (D’,H’). p-Smad phosphorylation is strongly reduced in fused myotubes (white arrows in H’) but is
clearly present in mononucleated myoblasts (white arrows in d’). Magnification is 100×.
Figure 7 Chordin expression is upregulated in myofiber
cultures. Gapdh, MyoD, Myogenin, Chordin and Bmp7 expression
was analyzed by RT-PCR of myofiber cultures at 0, 48 and 72 hours.
cDNA of an E 12.5 embryo was used as a control. Chordin
expression follows the expression of Myogenin.
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accompanied by the presence of numerous mononu-
cleated cells within the same areas (Figure 8C). 10 days
after injury myofiber morphology was restored and
showed typical signs of regenerated muscle, like cen-
trally located myonuclei and a small myofiber diameter
(Figure 8D). Quantitative RT-PCR analysis of Myogenin
expression during the regeneration process did not
detect increased expression levels 24 hours after trauma
compared to untreated controls (Figure 8E). A maxi-
mum of Myogenin expression was reached after 4 days,
indicating that satellite cell descendants committed to
differentiation were expanded in the injured muscle tis-
sue. 10 days after trauma, the expression of Myogenin
was decreased, but was still slightly elevated compared
to controls. To analyze BMP signaling in activated satel-
lite cells we used immunostaining against MyoD and p-
Smad in parallel to Laminin a2( L a m a 2 ) ,ap r o t e i no f
the basement lamina, which surrounds each myofiber
including the attached satellite cells (Figure 9). As the
highest level of regeneration seemed to occur 4 days
after injury (Figure 8C), we chose this time point for
our analysis. MyoD-positive cells underlying the base-
ment lamina were present within regenerating regions
(Figure 9A-D), demonstrating that 4 days after injury
the majority of mononucleated cells were satellite cell
descendants. Immunostaining for p-Smad together with
Lama2 on parallel sections (Figure 9E-H) identified p-
Smad-positive cells within the regenerating areas.
Furthermore, similar to the MyoD-positive cells, these
p-Smad-positive nuclei were located beneath the base-
ment lamina of single myofibers and were thus likely to
be satellite cell descendants. To further substantiate our
data, we analyzed the expression of MyoD and p-Smad
by double immunostaining using antibodies raised in
different species (goat anti-MyoD and rabbit anti-p-
Smad). We found both markers to be colocalized in a
subset of nuclei representing activated satellite cells in
the trauma region (Figure 9J). Together with the obser-
vation that postmitotic myonuclei of cultured myofibers
were not stimulated by exogenous Bmp7 treatment,
these data strongly support the hypothesis that activated
satellite cells respond to BMP signals in vivo during
muscle regeneration.
To investigate if BMP signaling is regulated endogen-
ously during the regeneration process we analyzed the
expression of BMPs and their inhibitors in vivo.W e
detected Bmp2, Bmp4, Bmp7 and Noggin expression in
regenerating muscle tissue, but we did not find their
expression increased upon trauma (data not shown).
Interestingly, while at day 1 after trauma induction,
when muscles were actively regenerating, Chordin
expression was slightly reduced, its expression was upre-
gulated at the end of the regeneration phase (day 10)
(Figure 9I). It is thus likely that, similar as in the ex vivo
cultures, BMP signaling is necessary for satellite cell
expansion, while downregulation of BMP signaling trig-
gers cell cycle exit and differentiation in vivo.
Discussion
In this study we investigated the function of BMP sig-
naling during satellite cell differentiation. Detailed analy-
sis revealed that satellite cells respond to BMP signals
during early stages of the activation process. BMP sig-
nals prevent cell cycle exit of activated satellite cells and
proliferating myoblasts, leading to an expansion of the
pool of satellite cell descendants. Furthermore, BMP sig-
naling seems to support Pax7 expression at early activa-
tion stages. In contrast, inhibition of BMP signaling
promotes cell cycle exit and differentiation leading to a
reduced number of myoblasts and enhanced myotube
formation. Interestingly, the BMP inhibitor Chordin is
Figure 8 Histological analysis of muscle after injury. Sections of
the gastrocnemius muscle before (A) and after trauma stained with
Toluidin blue reveal invasion of mononucleated cells after 1 day (B)
and massive regeneration after 4 days (C). 10 days after injury (D)
regeneration is nearly completed and multiple regenerated fibers
are visible. Magnification is 200×. (E) Expression analysis of Myogenin
showing highest expression levels after 4 days of injury (n = 6
control animals, n = 2 animals at day 1 and n = 3 animals at day 4
and day 10, respectively).
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lite cell cultures. Inhibition of BMP signaling might thus
support the transition from a proliferating to a differen-
tiating state. To test our hypothesis in vivo, we analyzed
muscle regeneration in a standardized injury mouse
model. Similar to the ex vivo experiments we found
BMP signaling upregulated in activated satellite cells at
early stages of differentiation. At later stages, when Myo-
genin expression decreases in the trauma muscle we
found Chordin expression upregulated. Based on these
data we propose a role for endogenous BMP signals in
expanding the pool of proliferating satellite cells and
preventing premature differentiation into myotubes. A
temporally coordinated, intrinsic inhibition of BMP sig-
nals by Chordin will subsequently regulate the pace of
the differentiation process.
Adult myogenesis recapitulate the embryonic program
Although BMP signals have been shown to regulate
myogenesis during embryonic and fetal development,
the role of BMP signaling during adult muscle regenera-
tion is not well understood yet. Within the somite,
Bmp4 from the lateral plate mesoderm and the overly-
ing ectoderm has been reported to increase the number
of Pax3-positive, proliferating myoblasts, whereas it
reduces the number of MyoD expressing cells [36,37]. A
detailed analysis revealed a feedback mechanism
between Bmp4 and its antagonist Noggin, during which
the expression of Noggin in the somites is induced by
Bmp4 from the ectoderm. This feedback mechanism is
thought to orchestrate proliferation and differentiation
of muscle precursor cells restricting differentiation to
cells in the deeper myotome [27]. Recently, BMPs have
also been described to positively regulate the number of
fetal myoblasts and myofibers during chick myogenesis
[28]. Here we show that BMP signals play a similar role
during satellite cell differentiation. Like during embryo-
nic muscle development, activation of BMP signaling
seems to keep primary myoblasts in an undifferentiated,
mononucleated state, whereas inhibition of BMP signal-
ing results in enhanced terminal differentiation of myo-
blasts into myofibers, thereby exhausting the pool of
mononucleated cells. BrdU incorporation analyses in
primary myoblast cultures did not reveal significant dif-
ferences in the percentage of mononucleated cells in S-
phase. It is thus not likely that BMP signaling plays a
major role in regulating cell cycle kinetics. Instead our
data are in agreement with the model that inhibition of
Figure 9 Activated BMP signaling during muscle regeneration. Parallel section ((A-D) and (E-H) represent images of 2 parallel sections) of
the regenerating gastrocnemius muscle 4 days after injury were analyzed for Lama (A,E), MyoD (B) and p-Smad (F). Nuclei are stained with DAPI
(C,G). Boxed areas in the overlay images (D,H) are enlarged in (D’,H’). Both, MyoD (A-D,D’) and p-Smad-positive nuclei (E-H,H’) are located
beneath the basement lamina of regenerating myofibers (white arrows in D’,H’). (J) Double immunostaining of MyoD, detected with a goat anti-
MyoD antibody (green), and p-Smad, detected with a rabbit anti-p-Smad antibody (red), revealed co-localization of both proteins in a subset of
nuclei (yellow, arrows) in the regenerating tissue. Nuclei were counterstained with DAPI (blue). Magnification is 400×. (I) Analysis of Chordin
expression by RT-PCR shows highest expression levels after 10 days of injury (n = 6 control animals, n = 2 animals at day 1 and n = 3 animals at
day 4 and day 10).
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differentiation process. This model is further supported
by the finding that the number of Myogenin-positive,
mononucleated cells committed to differentiate is
reduced after Bmp7 and Noggin treatment. We would
thus propose that, like in the somite, BMP signals pre-
vent the initiation of the differentiation program and the
fusion into myofibers. In contrast inhibition of BMP sig-
naling supports cell cycle exit, and commitment towards
the differentiated myoblast, subsequently accelerating
fusion into myofibers. Interestingly, it has recently been
published that quiescent cells (reserve cells) can be
detected in high density cultures of human fetal myo-
blasts [38]. Whether inhibition of differentiation and the
subsequently increased cell density after BMP treatment
will support such a reversion of cells into a quiescent
state will be an interesting question for future studies.
BMP signaling in satellite cells and osteoblast
differentiation
Initially, multiple observations indicated that ectopic
activation of BMP signaling in adult muscles is closely
linked to ectopic bone formation. Most importantly,
BMPs have been identified as ‘Bone morphogenetic
proteins’, which induce ectopic bone formation if
injected into rat muscle [22,39]. Furthermore, constitu-
tive activating mutations of the type I BMP receptor,
Acvr1, have been identified in the human syndrome
Fibrodysplasia ossificans progressiva (FOP). FOP
patients develop heterotopic ossifications in muscles
and soft tissue upon injury [40,41]. Subsequent analysis
of BMP signaling in the myogenic cell line C2C12
further demonstrated that C2C12 cells will differentiate
into osteoblasts upon stimulation with BMP
[22,24,25,39]. Recent gene expression studies revealed,
however, that at least 25% of genes regulated in C2C12
cells are not differentially expressed in primary satellite
cells [42]. Here we found that although BMP treatment
inhibits myogenic differentiation in both, C2C12 and
primary satellite cells, at least a subpool of C2C12 cells
will subsequently express osteoblast markers, like
Runx2 and alkaline phosphatase. In contrast, under the
conditions chosen in our study, myoblast derived from
primary satellite cells did not transdifferentiate into
osteoblast-like cells. In agreement with these observa-
tions, two elegant studies have recently shown that not
satellite cells, but a Tie2 expressing population of
endothelial cells, contributes to the heterotopic ossifi-
cations observed in FOP lesions [43,44]. Nevertheless,
although under in vivo conditions no bone formation
is found in regenerating muscles, experiments using
different cell culture conditions indicated that the dif-
ferentiation potential of satellite cells includes the
osteogenic cell fate in vitro [45].
BMPs as inhibitors of satellite cells differentiation
During regeneration, satellite cells differentiate into
myoblasts to restore the injured muscle and, in parallel,
maintain the stem cell pool. It is therefore necessary
that satellite cell proliferation, differentiation and fusion
are tightly regulated. Here we show that BMP signaling
plays a critical role in coordinating the differentiation of
satellite cells from a proliferative to commited state. A
proliferation promoting effect of BMPs has been
reported for different progenitor cells [46,47]. This effect
is, at least in part, mediated by members of the inhibitor
of differentiation/inhibitor of DNA binding (ID) family
of transcription factors, which are directly regulated by
BMP signaling on a transcriptional level [48,49]. Id pro-
teins act on the cell cycle machinery via different
mechanisms to keep cells in a proliferating state and
inhibit differentiation. Recently, it has been shown that
deletion of Id1/Id3 impaired muscle regeneration in
adult mice [50]. Furthermore, loss of these BMP-depen-
dent transcription factors led to decreased proliferation
in satellite cells. It is thus likely, that the inhibition of
differentiation we observed upon BMP stimulation
resulted from the activation of ID proteins.
In contrast to BMP treatment, depletion of BMP sig-
nals by Noggin induced fusion of myoblasts into myo-
tubes. Interestingly, in our satellite cell cultures the
relative number of Myogenin-positive, mononucleated
myoblasts was reduced in Noggin-treated cultures com-
pared to wild type cultures. Thus, inhibition of BMP sig-
naling seems to not only induce commitment to the
differentiation program, but to accelerate differentiation
into fused myotubes in addition. Our pulse-chase BrdU
labeling experiments further demonstrated that, upon
inhibition of BMP signaling, highly labeled nuclei were
found in the newly formed myotubes indicating that
inhibition of BMP signaling induced cell cycle exit.
Besides a direct effect on cell cycle exit, activation of the
BMP pathway might result in a down-regulation of dif-
ferentiation-promoting factors. Members of the MRF
family of transcription factors, including MyoD and
Myogenin, directly interact with Id proteins. This inter-
action prevents dimerization of MRFs with E-proteins
and, thereby, the activation of differentiation-promoting
target genes [51,52].
In this context it is interesting that we found the BMP
inhibitor Chordin upregulated during the differentiation
process ex vivo and in vivo. A Chordin-dependent
intrinsic inhibition of BMP signals, which we mimicked
by Noggin treatment in our experiments, might thus
support cell cycle exit and differentiation if sufficient
myoblast precursor cells have been generated. Whether
Chordin expression is regulated by the environment, as
for example by the number of progenitor cells, or by
differentiation-dependent intrinsic transcription factors
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studies.
In contrast to satellite cells and mononucleated myo-
blasts, fused myoblasts and nuclei of muscle fibers do
not show overt phosphorylation of SMAD proteins,
even upon Bmp7 treatment. This might reflect the
endogenous production of BMP inhibitors by myotubes,
which directly inhibit BMPs from binding to their recep-
tors. At later stages, postmitotic cells might switch into
a non-responive state by decreased expression of single
BMP pathway components or continuous expression of
inhibitors. Interestingly, when we cultured satellite cells
under serum-free conditions without Bmp7 supplemen-
tation, p-Smad signals were not completely absent,
although dramatically reduced compared to Bmp7-trea-
ted cells. The use of the artificial culture system does
not exclude that BMPs endogenously produced by the
satellite cells or fibers are sufficient to slightly activate
the BMP signaling cascade in culture. In this context it
is interesting to note that mechanical stress has been
shown to trigger phosphorylation of BMP responsive
SMAD proteins in other cell types like osteoblasts [53].
Pax7 expression is maintained by BMP signaling
During chick embryonic myogenesis BMP signals
derived from the ectoderm are required to maintain the
pool of Pax3 expressing myoblast [26,27]. Here we show
that in primary mouse satellite cells Pax7 expression is
maintained by Bmp7 treatment. The sustained Pax7
expression might thus contribute to the Bmp7-induced
delay in differentiation. Ina c c o r d a n c ew i t hs u c hat h e -
ory retroviral overexpression of Pax7 in primary satellite
cell descendants results in a delay in satellite cell differ-
entiation [54]. Pax7 has recently been shown to activate
the expression of Id3 [55]. As Pax7 and p-Smad share at
least one common target gene, both transcription factors
might have a synergistic function to activate promoters
of ID genes and other regulators of myoblast prolifera-
tion. Alternatively, as Pax7 has also been shown to be
dispensable for adult muscle regeneration [56], the
redundancy of these and other regulators of satellite cell
proliferation might guarantee muscle regeneration under
restricting conditions.
BMP signaling is activated in regenerating muscle fibers
in vivo
Recent studies have shown that Bmp4 and Bmp6 are
expressed in quiescent satellite cells and are upregulated
in C2C12 cells stably overexpressing Pax7 [55,57]. As
we could not detect p-Smad proteins in quiescent satel-
lite cells it is unlikely that p-Smad mediated BMP sig-
naling contributes to the maintenance of the stem cell
pool. The BMP inhibitor Chordin-like 2 (Chrdl-2),
which has been described to be specifically expressed in
quiescent satellite cells, might contribute to the inactiva-
tion of residual BMP signals [57].
Within our trauma model Bmp2, Bmp4 and Bmp7
expression was not increased. Nevertheless, p-Smad was
clearly activated during the regeneration process. It is
thus interesting to speculate that BMPs, like Hgf, are
stored within the extracellular matrix and are released
upon injury to trigger satellite cell expansion [14]. This
would allow a fast, transcription-independent activation
of the regeneration process. Similar to the ex vivo
experiments we found an up-regulation of the BMP
inhibitor Chordin in regenerating muscle tissue.
The in vivo data showed that Myogenin expression
was upregulated before Chordin was expressed.
Although Myogenin is often described as differentiation
marker, it has been reported that Myogenin expression
precedes cell cycle exit during myogenic differentiation
[58]. Our data would thus indicate that upon commit-
ment to myogenic differentiation the inhibition of BMP
signaling by an intrinsic upregulation of Chordin will
support cell cycle exit and terminal differentiation. In a
parallel study Noggin has recently been described to be
upregulated in trauma tissue [59] strongly supporting
our hypothesis that fine-tuning of BMP signaling is a
critical mechanism during the regeneration process.
Interaction of BMP signals with other signaling factors
Our analysis has clearly shown that BMPs regulate ske-
letal muscle regeneration. Other trophic factors like Hgf,
FGFs and TGFb have also been shown to balance prolif-
eration and differentiation of satellite cells, at least in
vitro.T h ee x p o s u r eo fq u i e s c e n t satellite cells, which
express the Hgf-receptor c-met, to Hgf, lead to the acti-
vation of satellite cells and their re-entry into the cell
cycle. Different lines of evidence indicate that Hgf is not
expressed upon injury but is released from storage in
the extacellular matrix allowing a fast induction of the
regeneration process [13-15]. As p-Smad phosphoryla-
tion in satellite cells could only be detected after 24
hours of myofiber cultures, it is likely that BMP signals
act downstream of Hgf-dependent activation of satellite
cells. In addition, Hgf signals stimulate the expansion of
the pool of satellite cell descendants and efficiently inhi-
bit their differentiation [13,60,61]. In this function they
are likely acting in parallel to BMP signals. Members of
the FGF family of growth factors have also been impli-
cated in promoting the proliferation of activated satel-
lites cells. Like BMPs they seem to act downstream of
Hgf [10,17,19]. It is interesting to note that at least
three signaling systems interact to maintain the expan-
sion of satellite cells. During the course of the differen-
tiation process we observed the expression of the BMP
inhibitor Chordin, which seems to support the initiation
of the differentiation program. A similar function has
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tion and differentiation of satellite cells [19]. It will be
an important task of future studies to decipher the epi-
static relationship and the modes of interaction for
these and other signaling systems in detail.
Conclusions
In summary, we propose a model (Figure 10), in which
satellite cells are activated in a BMP-independent
mechanism by Hgf. BMPs, possibly released from the
extracellular matrix, will then act in parallel to Hgf and
FGF signals and contribute to keep satellite cells in a
proliferating state. This effect is likely to be driven by
the activation of ID proteins by phosporylated SMAD
proteins. After satellite cells are committed to differenti-
ate they express increasing amounts of the BMP inhibi-
tor Chordin. Inhibition of BMP signaling, likely in
parallel with activated TGFb signaling, will support cell
cycle exit and initate the differentiation into myotubes.
At later stages during the regeneration process fused
myoblasts loose the competence to react to BMP signals




10-15 weeks old male C57BL6/J mice were bred and
kept according to institutional guidelines. 8-10 weeks
o l dm a l eB A L B / cm i c ew e r eo b t a i n e df r o mH a r l a n .
Muscle trauma in anaesthetized BALB/c mice was
induced as previously describ e d[ 3 5 ] .B r i e f l y ,ad r o p -
mass of 20 g (height 1.20 m) delivered a single impact
on the posterior part of the gastrocnemius muscle with-
out fracture of the bone. The trauma was induced on
both hindlimbs. 3 animals were used per time point
except 2 animals at day 1. Controls (n = 6) were anaes-
thetized only. Animals were sacrificed by cervical dislo-
cation and muscle tissue was dissected for further
processing.
Single fiber isolation and culture
Single fiber isolation was carried out as previously
described [62]. Mouse EDL muscles from C57BL/6
mice were carefully dissected and digested in 0.2% Col-
lagenase type I (Sigma). Myofibers were released from
t h et i s s u eb yg e n t l et i t u r a t i o na n dt r a n s f e r r e di n t o
DMEM/F12 medium containing 10% horse serum
(Invitrogen) and 0.5% chicken embryo extract (MP
Biomedicals) for up to 72 hours (floating myofiber cul-
tures). Serum-free cultures were kept in DMEM/F12
medium containing 20% serum replacement 2 (Sigma).
For satellite cell adhesion fibers were cultured in plat-
ing medium for 20 hours and each fiber was trans-
ferred into a single well of a 24-well plate coated with
matrigel (BD Biosciences). After adhesion, proliferation
medium containing DMEM/F12, 10% horse serum,
20% fetal bovine serum (Pan Biotech) and 1% chicken
embryo extract was added to the culture and satellite
cells were expanded for 4 days [63]. Differentiation
was induced by switching to DMEM/F12 medium con-
taining 10% horse serum, 2% fetal bovine serum and
0.5% chicken embryo extract. Cultures were supple-
mented with 100 ng/ml Bmp7 or 125 ng/ml Noggin
(RnD systems). Medium and growth factors were
replaced daily.
C2C12 cell culture
C2C12 cells (DSMZ) were maintained subconfluent in
DMEM containing 10% fetal bovine serum. For differen-
tiation analysis 2 × 10
4 cells/cm
2 were seeded and
grown for further 24 hours. Differentiation was induced
by switching to DMEM containing 2% horse serum.
Cultures were supplemented with 100 ng/ml Bmp7 or
125 ng/ml Noggin (RnD systems). Medium and growth
factors were replaced every day. For proliferation analy-
sis 10 μM5 - b r o m o - 2 ’-deoxyuridine (BrdU) (Roche) was
added to the culture 2 hour prior to fixation, unless
otherwise mentioned (Figure 5).
Tissue processing
Unfixed gastrocnemius muscles were carefully dissected
from the hindlimb of injured mice and embedded in
O C T( S a k u r a ) .T i s s u es a m p l e sw e r ef r o z e ni nl i q u i d
nitrogen-cooled isopentane. 10 μm serial cryosections
(Mikrom) were mounted on Superfrost slides (Roth) and
Figure 10 Function of BMP signaling during satellite cell
differentiation. Quiescent satellite cells (green) do not respond to
BMP signals. Upon activation, satellite cells express MyoD and
respond to BMP signals with phosphorylation of p-Smad (red) and
reduced differentiation. After satellite cell descendents are
committed to differentiate (yellow) they express Myogenin and
subsequently the BMP inhibitor Chordin. Upon inhibition of BMP
signaling, myoblasts exit the cell cycle, fuse into myotubes and
undergo terminal differentiation (purple). Postmitotic myonuclei
(blue) irreversibly loose the competence to respond to BMP signals.
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OCT was removed and sections were stained in 0.1%
Toluidin Blue (Merck).
Immunostaining
For immunostaining, myofibers, satellite cell cultures
and sections were washed in PBS and fixed in 4% paraf-
ormaldehyde (PFA). Cultures processed for BrdU detec-
tion were incubated in 2 N HCl for 30 minutes followed
by neutralization in 0.1 M Na2B4O7 for 10 minutes.
After washing, permeabilisation was carried out in 0.5%
TritonX100/PBS (PBT) followed by blocking in 10%
goatserum in 0.05% PBT. Antibodies diluted in blocking
reagent were applied over night at 4°C. Secondary anti-
bodies were applied for 45 minutes and followed by
counterstaining with 100 ng/ml DAPI (Roth) in PBS for
5 minutes. Primary antibodies used were mouse anti-
Pax7 and mouse anti-Myosin (clone A4.1025, DSHB),
mouse anti-Myogenin (DAKO cytomation), rabbit anti-
MyoD (Santa Cruz, except for Figure 9J), rabbit anti-
phospho-Smad 1/5/8 and rabbit anti-cleaved Caspase-3
(Cell Signaling Technologies), rat anti-BrdU (Abcam),
rabbit anti-Desmin (Sigma) in appropiate dilutions.
Detection of primary antibodies was carried out using
Alexa 488 and Alexa 568 fluorochrome-coupled second-
ary antibodies (Molecular Probes). For tissue double
labeling (Figure 9J) goat anti-MyoD (Santa Cruz, N-19)
and rabbit anti-phospho-Smad 1/5/8 (Cell Signaling
Technologies) were used. Secondary detection was car-
ried out using Alexa-fluorochrome-coupled secondary
antibodies (Molecular probes) raised in donkey.
Alkaline phosphatase activity assay
Adherent cells were washed in PBS and fixed in 4% PFA
for 10 minutes. After several washes in PBS, cells were
preincubated in 100 mM Tris pH 9.5, 100 mM NaCl
and 50 mM MgCl2 (NTM). NBT/BCIP substrate
(Roche) was diluted in NTM and applied to the cells for
45 minutes. Internal positive control on primary cells
was carried out by incubating fixed cells with a Fgf8-
alkaline phosphatase fusion protein. Cells were treated
as described above.
RNA isolation and PCR analysis
RNA was isolated using Trizol (Invitrogen) and cDNA
was prepared using Superscript III (Invitrogen) accord-
ing to the manufacturer’s instructions. Quantitative PCR
was performed on a Step one plus realtime PCR system
(Applied Biosystems) using EVA green PCR master mix
(Biobudget) according to the manufacturer’sg u i d e l i n e s .
b2-miroglobulin was used as reference. Relative quantifi-
cation was carried out using the method of Pfaffl [64].
Semi-quantitative PCR was carried out using DreamTaq
Polymerase (Fermentas) on Biometra cycler. Primers
used were as follows: Gapdh for: 5’CCAGGAGCGA-
GACCCCACTA3’; Gapdh rev: 5’GCAGTTGGTGGTGC
AGGATG3’; b2mfor: 5’GCTCGGTGACCCTGGT
CTTT3’; b2mrev: 5’GAGGCGGGTGGAACTG
TGTT3’; MyoD for: 5’CGAGCACTACAGTGGCGACT
CAGAT3’; MyoD rev: 5’GCTCCACTATGCTGGA
CAGGCAGT3’; Myogenin for: 5’CCATCCAGTACATT-
GAGCGCCTACA3’; Myogenin rev: 5’ACGATGGACG
TAAGGGAGTGCAGAT3’; Chordin for: 5’ ATAGCCC
TGCTCACCCTC AGTGACA3’; Chordin rev: 5’GCTCC
AACCAGTCCATCTCTTGGTC3’; Bmp7 for: 5’CCTGT
CCATCTTAGGGTTGC; Bmp7 rev: 5’CAGTGAGG
AAGTGGCTGTCC3’.
Imaging and statistical analysis
Fluorescence pictures were taken on a Zeiss Axiovert
200 microscope with a Spot 23.0 camera (Diagnostic
Instruments) and Metamorph Imaging Software (Visi-
tron Imaging systems). For each experiment done in
triplicates, 10 pictures/well were randomly taken at
200-fold magnification. The Metamorph cell cycle tool
was used to count nuclei and BrdU or Myosin-positive
C2C12 cells. For primary satellite cell descendants, 2
individual pictures from the middle of each clone were
taken in a 100-fold magnification and cells were
counted and categorized manually. Quantification of
fluorescence signal intensity was performed using the
Metamorph image analysis tool. In short, the fluores-
cence intensity in the nucleus was measured and
related to the total area of the nucleus. Statistic signifi-
cance was assessed using the generalized Wilcoxon
test (for Myosin-positive cells) or Wilcoxon test (for
all other experiments). p-values < 0.05 were regarded
as significant. Diagrams show mean values. Bars indi-
cate standard deviation.
Additional material
Additional file 1: Figure S1 BMP signaling does not alter cell cycle
kinetics of myoblasts. Myoblasts were differentiated in control medium
(A-C,C) or in medium supplemented with Bmp7 (D-F,F) or Noggin (G-I,I)
for 3 days and labeled for two hours with BrdU at the end of the
cultivation phase. (J) No statistically significant alteration of the
percentage of cells in S-phase within the pool of mononucleated
myoblasts could be detected after Bmp7 (p = 0.11) or Noggin (p = 0.66)
treatment (n > 6 individual cultures per treatment from 2 independent
experiments). Boxed areas in (C,F,I) are enlarged in (C’,F’,I’). Magnification
is 100×.
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